Analgesics Outlook 2034: Key Drivers, Trends, and Market Frontiers
Discover trends, market shifts, and competitive outlooks for the analgesics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Are the Key Milestones in the Analgesics Market’s Growth Trajectory From 2025 To 2034?
The size of the analgesics market has seen consistent growth in the past few years. The market, worth $109.97 billion in 2024, is projected to increase to $113.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The historic period of growth has been driven by various factors including the influence of alternative therapies, the results of safety and efficacy studies, the widespread prevalence of pain, extensive marketing and promotional activities, and economic influences.
Over the coming years, the analgesics market is forecasted to witness consistent growth, reaching a value of $129.46 billion in 2029 with a compound annual growth rate (CAGR) of 3.2%. This growth estimation for the forecast period is influenced by factors such as alternative pain management strategies, competitive marketplace dynamics, heightened public health consciousness, demographic changes, and the increase in chronic illnesses. Key trends that will define the forecast period’s landscape include individualised treatments, non-opioid relief options, the use of CBD and cannabinoids, targeted pain management, and improved accessibility and affordability.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnalgesics Market?
The analgesics market is being propelled forward due to an increase in the incidence of chronic illnesses. Painkillers, also known as analgesic drugs, are commonly used to alleviate persistent or intense pain from various medical conditions. According to a report from the Switzerland-based health organization WHO in September 2022, chronic diseases or noncommunicable diseases (NCDs) evolve over a long time due to a mix of genetic, physiological, environmental, and behavioral factors. These NCDs contribute to 41 million deaths per year, making up 74% of all global deaths. Approximately 17 million people die annually from an NCD before reaching the age of 70. These premature deaths represent 86% of the mortality in lower and middle-income nations, and 77% of NCD-related deaths happen in these same nations. Thus, the increased incidence of chronic illnesses is fuelling the expansion of the analgesics market.
Which Segments in the Analgesics Offer the Most Growth?
The analgesics market covered in this report is segmented –
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnalgesics Market?# Market?
North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Analgesics Industry?
Growth by investment is becoming a prominent focus for companies in the analgesics market. Top-notch analgesic drug producers are increasing their stakes in clinical-stage firms to enhance their competitiveness and reinforce their presence in the market. Such investments facilitate these firms in broadening their geographic reach and securing expert skills in new product research and development. For example, in January 2022, Concentric Analgesics, Inc., a clinical-stage biopharmaceutical firm based in the US, completed a $20 million convertible note financing arrangement with a group of new and returning investors. This capital will be directed towards activating Phase 3 trials for Vocacapsaicin, the company’s prime product candidate on the verge of entering Phase 3. The funds will also be used to boost the Phase 3 development works for Vocacapsaicin, the main therapeutic candidate of Concentric Analgesics for dealing with post-operative pain. The financing completion signifies an essential milestone for Concentric Analgesics as it aids the firm in progressing Vocacapsaicin into Phase 3 development and lays the groundwork for fully financing the program up to the NDA submission stage.
View the full report here:
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report
What Are the Key Elements That Define the Analgesics Market?
Analgesics are the pain killers that are used to treat mild or severe pain, including musculoskeletal pain, surgical, trauma pain, cancer pain, or another type of pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model